A citation-based method for searching scientific literature

David A Zisman, Marvin Schwarz, Kevin J Anstrom, Harold R Collard, Kevin R Flaherty, Gary W Hunninghake. N Engl J Med 2010
Times Cited: 363







List of co-cited articles
853 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
Ganesh Raghu, Juergen Behr, Kevin K Brown, Jim J Egan, Steven M Kawut, Kevin R Flaherty, Fernando J Martinez, Steven D Nathan, Athol U Wells, Harold R Collard,[...]. Ann Intern Med 2013
305
51

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
41

Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.
Martin Kolb, Ganesh Raghu, Athol U Wells, Jürgen Behr, Luca Richeldi, Birgit Schinzel, Manuel Quaresma, Susanne Stowasser, Fernando J Martinez. N Engl J Med 2018
117
41

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
34

Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia.
Tamera J Corte, Gregory J Keir, Konstantinos Dimopoulos, Luke Howard, Paul A Corris, Lisa Parfitt, Claire Foley, Monica Yanez-Lopez, Daphne Babalis, Philip Marino,[...]. Am J Respir Crit Care Med 2014
108
33

Sildenafil preserves exercise capacity in patients with idiopathic pulmonary fibrosis and right-sided ventricular dysfunction.
MeiLan K Han, David S Bach, Peter G Hagan, Eric Yow, Kevin R Flaherty, Galen B Toews, Kevin J Anstrom, Fernando J Martinez. Chest 2013
120
32

BUILD-3: a randomized, controlled trial of bosentan in idiopathic pulmonary fibrosis.
Talmadge E King, Kevin K Brown, Ganesh Raghu, Roland M du Bois, David A Lynch, Fernando Martinez, Dominique Valeyre, Isabelle Leconte, Adele Morganti, Sébastien Roux,[...]. Am J Respir Crit Care Med 2011
305
32

Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis.
Christopher J Lettieri, Steven D Nathan, Scott D Barnett, Shahzad Ahmad, Andrew F Shorr. Chest 2006
512
30

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
28

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis.
Talmadge E King, Jürgen Behr, Kevin K Brown, Roland M du Bois, Lisa Lancaster, Joao A de Andrade, Gerd Stähler, Isabelle Leconte, Sébastien Roux, Ganesh Raghu. Am J Respir Crit Care Med 2008
374
28

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
27

Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial.
Ganesh Raghu, Rachel Million-Rousseau, Adele Morganti, Loyc Perchenet, Juergen Behr. Eur Respir J 2013
158
26

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau, David Montani, David S Celermajer, Christopher P Denton, Michael A Gatzoulis, Michael Krowka, Paul G Williams, Rogerio Souza. Eur Respir J 2019
22

Pulmonary hypertension in chronic lung disease and hypoxia.
Steven D Nathan, Joan A Barbera, Sean P Gaine, Sergio Harari, Fernando J Martinez, Horst Olschewski, Karen M Olsson, Andrew J Peacock, Joanna Pepke-Zaba, Steeve Provencher,[...]. Eur Respir J 2019
207
21

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
20

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
932
20

Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant.
A F Shorr, J L Wainright, C S Cors, C J Lettieri, S D Nathan. Eur Respir J 2007
211
20

Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study.
Steven D Nathan, Jürgen Behr, Harold R Collard, Vincent Cottin, Marius M Hoeper, Fernando J Martinez, Tamera J Corte, Anne M Keogh, Hanno Leuchte, Nesrin Mogulkoc,[...]. Lancet Respir Med 2019
54
37

Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial.
Hossein Ardeschir Ghofrani, Ralph Wiedemann, Frank Rose, Ralph T Schermuly, Horst Olschewski, Norbert Weissmann, Andreas Gunther, Dieter Walmrath, Werner Seeger, Friedrich Grimminger. Lancet 2002
497
19


Pulmonary hypertension in patients with idiopathic pulmonary fibrosis.
Hassan F Nadrous, Patricia A Pellikka, Michael J Krowka, Karen L Swanson, Nithima Chaowalit, Paul A Decker, Jay H Ryu. Chest 2005
256
17


Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
Motohiro Kimura, Hiroyuki Taniguchi, Yasuhiro Kondoh, Tomoki Kimura, Kensuke Kataoka, Osamu Nishiyama, Hiromichi Aso, Koji Sakamoto, Yoshinori Hasegawa. Respiration 2013
123
17

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis.
Imre Noth, Kevin J Anstrom, Sara Bristol Calvert, Joao de Andrade, Kevin R Flaherty, Craig Glazer, Robert J Kaner, Mitchell A Olman. Am J Respir Crit Care Med 2012
310
16

Pulmonary hypertension in idiopathic pulmonary fibrosis with mild-to-moderate restriction.
Ganesh Raghu, Steven D Nathan, Juergen Behr, Kevin K Brown, James J Egan, Steven M Kawut, Kevin R Flaherty, Fernando J Martinez, Athol U Wells, Lixin Shao,[...]. Eur Respir J 2015
72
20

Pulmonary hypertension in chronic lung diseases.
Werner Seeger, Yochai Adir, Joan Albert Barberà, Hunter Champion, John Gerard Coghlan, Vincent Cottin, Teresa De Marco, Nazzareno Galiè, Stefano Ghio, Simon Gibbs,[...]. J Am Coll Cardiol 2013
348
15

Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis.
Kunio Hamada, Sonoko Nagai, Shigeru Tanaka, Tomohiro Handa, Michio Shigematsu, Taishi Nagao, Michiaki Mishima, Masanori Kitaichi, Takateru Izumi. Chest 2007
253
15

Sildenafil improves walk distance in idiopathic pulmonary fibrosis.
Harold R Collard, Kevin J Anstrom, Marvin I Schwarz, David A Zisman. Chest 2007
148
15

Pulmonary Hypertension in Patients with Chronic Fibrosing Idiopathic Interstitial Pneumonias.
Marius M Hoeper, Juergen Behr, Matthias Held, Ekkehard Grunig, C Dario Vizza, Anton Vonk-Noordegraaf, Tobias J Lange, Martin Claussen, Christian Grohé, Hans Klose,[...]. PLoS One 2015
48
29

Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis.
H Olschewski, H A Ghofrani, D Walmrath, R Schermuly, B Temmesfeld-Wollbruck, F Grimminger, W Seeger. Am J Respir Crit Care Med 1999
253
14

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
930
14

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.
Aaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter Engel, Abubakr Bajwa, Roblee Allen, Jeremy Feldman, Rahul Argula, Peter Smith,[...]. N Engl J Med 2021
67
20

Efficacy and safety of sildenafil added to pirfenidone in patients with advanced idiopathic pulmonary fibrosis and risk of pulmonary hypertension: a double-blind, randomised, placebo-controlled, phase 2b trial.
Jürgen Behr, Steven D Nathan, Wim A Wuyts, Nesrin Mogulkoc Bishop, Demosthenes E Bouros, Katerina Antoniou, Julien Guiot, Mordechai R Kramer, Klaus-Uwe Kirchgaessler, Monica Bengus,[...]. Lancet Respir Med 2021
31
45

Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial.
Isabel Blanco, Salud Santos, Joaqím Gea, Rosa Güell, Ferran Torres, Elena Gimeno-Santos, Diego A Rodriguez, Jordi Vilaró, Begona Gómez, Josep Roca,[...]. Eur Respir J 2013
102
13

Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial.
Marius M Hoeper, Michael Halank, Heinrike Wilkens, Andreas Günther, Gerrit Weimann, Irmingard Gebert, Hanno H Leuchte, Jürgen Behr. Eur Respir J 2013
94
13

Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.
Rajeev Saggar, Dinesh Khanna, Anjali Vaidya, Ariss Derhovanessian, Paul Maranian, Erin Duffy, John A Belperio, Sam S Weigt, Shiv Dua, Shelley S Shapiro,[...]. Thorax 2014
41
31

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.
Luca Richeldi, Ulrich Costabel, Moises Selman, Dong Soon Kim, David M Hansell, Andrew G Nicholson, Kevin K Brown, Kevin R Flaherty, Paul W Noble, Ganesh Raghu,[...]. N Engl J Med 2011
669
13

Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.
Patrizio Vitulo, Anna Stanziola, Marco Confalonieri, Daniela Libertucci, Tiberio Oggionni, Paola Rottoli, Giuseppe Paciocco, Fabio Tuzzolino, Lavinia Martino, Marta Beretta,[...]. J Heart Lung Transplant 2017
48
25

Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.
Andrew R Goudie, Brian J Lipworth, Pippa J Hopkinson, Li Wei, Allan D Struthers. Lancet Respir Med 2014
67
17

Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots.
Steven D Nathan, Paul W Noble, Rubin M Tuder. Am J Respir Crit Care Med 2007
148
12

An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.
William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells,[...]. Am J Respir Crit Care Med 2013
12

Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis.
Steven D Nathan, Oksana A Shlobin, Shahzad Ahmad, Susan Urbanek, Scott D Barnett. Chest 2007
156
12

Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Ganesh Raghu, Valeria C Amatto, Jürgen Behr, Susanne Stowasser. Eur Respir J 2015
206
12

Sildenafil therapy and exercise tolerance in idiopathic pulmonary fibrosis.
Robert M Jackson, Marilyn K Glassberg, Carol F Ramos, Pablo A Bejarano, Ghazwan Butrous, Orlando Gómez-Marín. Lung 2010
49
24

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
12

Effect of bosentan upon pulmonary hypertension in chronic obstructive pulmonary disease.
Giuseppe Valerio, Pierluigi Bracciale, Anna Grazia D'Agostino. Ther Adv Respir Dis 2009
67
16

A randomised, controlled trial of bosentan in severe COPD.
D Stolz, H Rasch, A Linka, M Di Valentino, A Meyer, M Brutsche, M Tamm. Eur Respir J 2008
201
11

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial.
Talmadge E King, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Phil Hormel, Lisa Lancaster, Paul W Noble, Steven A Sahn, Javier Szwarcberg, Michiel Thomeer,[...]. Lancet 2009
354
11

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.
Fernando J Martinez, Joao A de Andrade, Kevin J Anstrom, Talmadge E King, Ganesh Raghu. N Engl J Med 2014
303
11

Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease.
Selim M Arcasoy, Jason D Christie, Victor A Ferrari, Martin St John Sutton, David A Zisman, Nancy P Blumenthal, Alberto Pochettino, Robert M Kotloff. Am J Respir Crit Care Med 2003
571
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.